Early OspA immune complex formation in animal models of Lyme disease

Journal of Molecular Microbiology and Biotechnology

Volumn 5, Issue 3, 2003, Pages 167-171

  Schutzer, Steven E ^a   Luan, Jennifer ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Animal models; Antigen antibody complexes; Borrelia burgdorferi; Immune complexes; Lyme disease; OspA; Outer surface proteins

Indexed keywords

AVIDIN; BIOTIN; OUTER SURFACE PROTEIN A; PROTEIN; UNCLASSIFIED DRUG; BACTERIAL VACCINE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN M; LIPOPROTEIN; MEMBRANE ANTIGEN; OUTER MEMBRANE PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BORRELIA BURGDORFERI; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC TEST; IMMUNE RESPONSE; IMMUNOBLOTTING; INOCULATION; LYME DISEASE; METHODOLOGY; NONHUMAN; PATHOGENESIS; T LYMPHOCYTE; TICK; ANIMAL; BLOOD; C3H MOUSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HAPLORHINI; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PATHOPHYSIOLOGY; RABBIT;

ACARI; ANIMALIA; BORRELIA; BORRELIA BURGDORFERI; ORYCTOLAGUS CUNICULUS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HAPLORHINI; HUMANS; IMMUNOGLOBULIN M; LIPOPROTEINS; LYME DISEASE; MICE; MICE, INBRED C3H; RABBITS;

EID: 0042238067     PISSN: 14641801     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070267     Document Type: Article

References (18)

1. Aguero-Rosenfeld, M.E., Nowakowski, J., Bittker, S., Cooper, D., Nadelman, R.B., and Wormser, G.P. 1996. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J. Clin. Microbiol. 34:1-9.
2. Barthold, S.W., de Souza, M.S., Janotka, J.L., Smith, A.L., and Persing, D.H. 1993. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol 143:959-971.
3. Benach, J.L., Bosler, E.M., Hanrahan, J.P., Coleman, J.L., Habicht, G.S., Bast, T.F., Cameron, D.J., Ziegler, J.L., Barbour, A.G., Burgdorfer, W., Edelman, R., and Kaslow, R.A. 1983. Spirochetes isolated from the blood of two patients with Lyme disease. N. Engl. J. Med. 308:740-742.
4. Dunn, J.J., Lade, B.N., and Barbour, A.G. 1990. Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr. Purif. 1:159-168.
5. Foley, D.M., Gayek, R.J., Skare, J.T., Wagar, E.A., Champion, C.I., Blanco, D.R., Lovett, M.A., and Miller, J.N., 1995. Rabbit model of Lyme borreliosis: erythema migrans, infection-derived immunity, and identification of Borrelia burgdorferi proteins associated with virulence and protective immunity. J. Clin. Invest. 96:965-975.
6. Malawista, S.E., Barthold, S.W., and Persing, D.H. 1994. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment. J. Infect. Dis. 170:1312-1316.
7. Montgomery, R.R., Malawista, S.E., Feen, K.J., and Bockenstedt, L.K. 1996. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: Exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183:261-269.
8. Moody, K.D., Adams, R.L., and Barthold, S.W. 1994. Effectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice. Antimicrob. Agents Chemother. 38:1567-1572.
9. Philipp, M.T., Aydintug, M.K., Bohm, R.P., Jr., Cogswell, F.B., Dennis, V.A., Lanners, H.N., Lowrie, R.C., Jr., Roberts, E.D., Conway, M.D., Karacorlu, M., and et al., 1993. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect. Immun. 61:3047-3059.
10. Rahn, D.W., and Malawista, S.E. 1991. Lyme disease: recommendations for diagnosis and treatment. Ann. Intern. Med. 114:472-481.
11. Roberts, E.D., Bohm, R.P., Jr., Cogswell, F.B., Lanners, H.N., Lowrie, R.C., Jr., Povinelli, L., Piesman, J., and Philipp, M.T., 1995. Chronic lyme disease in the rhesus monkey. Lab. Invest. 72:146-160.
12. Schutzer, S.E., Coyle, P.K., Belman, A.L., Golightly, M.G., and Drulle, J. 1990. Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 335:312-315.
13. Schutzer, S.E., Coyle, P.K., Dunn, J.J., Luft, B.J., and Brunner, M. 1994. Early and specific antibody response to OspA in Lyme Disease. J. Clin. Invest. 94:454-457.
14. Schutzer, S.E., Coyle, P.K., Reid, P., and Holland, B. 1999. Borrelia burgdorferi-specific immune complexes in acute Lyme disease. JAMA 282:1942-1946.
15. Schwan, T.G., Piesman, J., Golde, W.T., Dolan, M.C., and Rosa, P.A. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. U.S.A. 92:2909-2913.
16. de Silva, A.M., Telford, S.R.3., Brunet, L.R., Barthold, S.W., and Fikrig, E. 1996. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183:271-275.
17. Steere, A.C., Grodzicki, R.L., Kornblatt, A.N., Craft, J.E., Barbour, A.G., Burgdorfer, W., Schmid, G.P., Johnson, E., and Malawista, S.E. 1983. The spirochetal etiology of Lyme disease. N. Engl. J. Med. 308:733-740.
18. Steere, A.C., Sikand, V.K., Meurice, F., Parenti, D.L., Fikrig, E., Schoen, R.T., Nowakowski, J., Schmid, C.H., Laukamp, S., Buscarino, C., and Krause, D.S. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N. Engl. J. Med. 339:209-215.